IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Remus Pharmaceuticals IPO is a book build IPO listing on NSE EMERGE exchange. The company is based in Ahmedabad and caters to Pharmaceutical sector. Beeline Capital Advisors Private is the merchant banker of Remus Pharmaceuticals IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 10th March 2023.
Remus Pharmaceuticals IPO open date is 17th May 2023 and close date is 19th May 2023. IPO Allotment Date is 24th May 2023 and Listing date is 29th May 2023.Remus Pharmaceuticals IPO size is Rs 47.69 Cr. crores with IPO price of Rs 1229.00 Cr.. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Beeline Capital Advisors Private Limited is the book-running lead manager of the Remus Pharmaceuticals IPO. Link Intime India Private Limited is the Registrar and Market Maker is Sunflower Broking Private Limited for Remus Pharmaceuticals IPO.
Remus Pharmaceuticals IPO anchor investors are the below investors. The number of anchor investors in this IPO is 2.
| Anchor Investor Name | No. of shares Allotted | Offer Price (in Rs.) | Amount Invested (in Rs.) |
|---|---|---|---|
| Nav Capital Vcc | 8,800.00 | ₹1,229.00 | ₹10,815,200.00 |
| Chhattisgarh Investments Limited | 101,700.00 | ₹1,229.00 | ₹124,989,300.00 |
Remus Pharmaceuticals IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Remus Pharmaceuticals IPO, based in Ahmedabad, operates in the Pharmaceutical sector with a focus on Marketing and distribution pharmaceutical drugs. The company is launching its SME IPO on the NSE EMERGE exchange, using the Book Building Issue method. Remus Pharmaceuticals IPO size is ₹ 47.69 Cr. Crores with fresh issue size of Rs 47.69 Cr. Crores and Offer for sale being Nil.
The IPO allotment date for Remus Pharmaceuticals IPO is expected to be 24th May 2023, after the finalization of basis of allotment. Investors can check Remus Pharmaceuticals IPO allotment status on the registrars website, Link Intime India Private Limited. Remus Pharmaceuticals IPO refund dates are 25th May 2023.
Remus Pharmaceuticals IPO is expected to be listed on 29th May 2023.
The upper price band for the Remus Pharmaceuticals IPO is set at ₹ 1229.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Remus Pharmaceuticals IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Remus Pharmaceuticals IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 19th May 2023. After submission, funds are blocked until the basis of allotment of Remus Pharmaceuticals IPO is finalised.
The merchant banker for Remus Pharmaceuticals IPO is Beeline Capital Advisors Private Limited . Beeline Capital Advisors Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Remus Pharmaceuticals IPO RHP for further details.
The registrar for Remus Pharmaceuticals IPO is Link Intime India Private Limited. Investors can go to Link Intime India Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Remus Pharmaceuticals IPO through their official website or helpline.
Remus Pharmaceuticals IPO was subscribed 57.21 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 47.69 Cr.
Avg IPO Size (Sector Based)
:
₹ 23.81 Cr.
Sector: Pharmaceutical
SME IPO so far:
34
Merchant Banker:
Beeline Capital
SME IPO by BRLM so far:
47
City:
Ahmedabad
SME IPO so far:
174
Revenue (annualised):
₹ 44.81 cr.
PE
Ratio:
21.09x
Average Sector PE Ratio: 20.29x
Remus Pharmaceuticals IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Remus Pharmaceuticals Financial Review Page
Merchant Banker(s) of Remus Pharmaceuticals IPO: Beeline Capital Advisors Private Limited
Remus Pharmaceuticals IPO subscription was 57.21 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Remus Pharmaceuticals IPO listed at a listing price of 1711.00 against the offer price of 1229.00.
The current market price of Remus Pharmaceuticals is 2004.00.
Why Us?
